HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

M J van Den Brand Selected Research

fradafiban

4/2001Pharmacodynamics and safety of lefradafiban, an oral platelet glycoprotein IIb/IIIa receptor antagonist, in patients with stable coronary artery disease undergoing elective angioplasty.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


M J van Den Brand Research Topics

Disease

1Coronary Artery Disease (Coronary Atherosclerosis)
04/2001
1Hemorrhage
04/2001
1Stable Angina
04/2001

Drug/Important Bio-Agent (IBA)

1fradafibanIBA
04/2001
1lefradafibanIBA
04/2001
1Glycoproteins (Glycoprotein)IBA
04/2001
1Platelet Membrane GlycoproteinsIBA
04/2001

Therapy/Procedure

1Punctures
04/2001